Fairview Capital Investment Management LLC cut its position in AmerisourceBergen Corp. (NYSE:ABC) by 3.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,370 shares of the company’s stock after selling 400 shares during the quarter. Fairview Capital Investment Management LLC’s holdings in AmerisourceBergen were worth $845,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of ABC. Clarus Wealth Advisors lifted its holdings in AmerisourceBergen by 12.2% during the 4th quarter. Clarus Wealth Advisors now owns 1,308 shares of the company’s stock worth $97,000 after buying an additional 142 shares during the last quarter. Lenox Wealth Management Inc. lifted its holdings in AmerisourceBergen by 2.0% during the 4th quarter. Lenox Wealth Management Inc. now owns 8,379 shares of the company’s stock worth $623,000 after buying an additional 163 shares during the last quarter. Strategic Wealth Partners Ltd. lifted its holdings in AmerisourceBergen by 5.4% during the 3rd quarter. Strategic Wealth Partners Ltd. now owns 3,201 shares of the company’s stock worth $295,000 after buying an additional 164 shares during the last quarter. Buckley Wealth Management LLC lifted its holdings in AmerisourceBergen by 2.7% during the 4th quarter. Buckley Wealth Management LLC now owns 7,155 shares of the company’s stock worth $532,000 after buying an additional 190 shares during the last quarter. Finally, Regentatlantic Capital LLC lifted its holdings in AmerisourceBergen by 4.8% during the 4th quarter. Regentatlantic Capital LLC now owns 4,344 shares of the company’s stock worth $323,000 after buying an additional 197 shares during the last quarter. 66.46% of the stock is owned by institutional investors and hedge funds.

A number of analysts have issued reports on the company. Morgan Stanley lifted their price target on AmerisourceBergen from $88.00 to $91.00 and gave the stock an “equal weight” rating in a report on Monday, December 3rd. Royal Bank of Canada decreased their price target on AmerisourceBergen from $90.00 to $87.00 and set a “hold” rating for the company in a report on Friday, November 30th. Zacks Investment Research downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Friday, March 8th. Barclays reaffirmed a “hold” rating and set a $84.00 price target on shares of AmerisourceBergen in a report on Sunday, January 6th. Finally, TheStreet downgraded AmerisourceBergen from a “b” rating to a “c+” rating in a report on Tuesday, March 19th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $88.33.

In related news, CFO James F. Cleary, Jr. purchased 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 6th. The shares were purchased at an average price of $77.52 per share, for a total transaction of $155,040.00. Following the transaction, the chief financial officer now directly owns 7,306 shares of the company’s stock, valued at approximately $566,361.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Dale Danilewitz sold 543 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $78.77, for a total value of $42,772.11. Following the completion of the transaction, the insider now owns 2,171 shares in the company, valued at approximately $171,009.67. The disclosure for this sale can be found here. Over the last three months, insiders bought 2,018 shares of company stock valued at $156,471 and sold 110,411 shares valued at $8,978,127. 27.80% of the stock is currently owned by insiders.

AmerisourceBergen stock opened at $77.89 on Friday. AmerisourceBergen Corp. has a fifty-two week low of $69.36 and a fifty-two week high of $95.00. The company has a quick ratio of 0.53, a current ratio of 0.94 and a debt-to-equity ratio of 1.43. The stock has a market capitalization of $16.15 billion, a PE ratio of 11.72, a PEG ratio of 1.41 and a beta of 1.13.

AmerisourceBergen (NYSE:ABC) last posted its earnings results on Thursday, January 31st. The company reported $1.60 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.50 by $0.10. AmerisourceBergen had a return on equity of 44.53% and a net margin of 0.69%. The business had revenue of $45.39 billion during the quarter, compared to the consensus estimate of $43.52 billion. On average, equities research analysts expect that AmerisourceBergen Corp. will post 6.76 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Monday, March 4th. Stockholders of record on Tuesday, February 19th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.05%. The ex-dividend date was Friday, February 15th. AmerisourceBergen’s payout ratio is currently 24.65%.

TRADEMARK VIOLATION WARNING: “Fairview Capital Investment Management LLC Reduces Stake in AmerisourceBergen Corp. (ABC)” was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/fairview-capital-investment-management-llc-reduces-stake-in-amerisourcebergen-corp-abc/2925580.html.

AmerisourceBergen Profile

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Read More: Quiet Period Expirations

Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.